Frank L. Douglas
Douglas graduated from Lehigh University, received his M.D. and Ph.D. degrees from Cornell University, completed an internship and residency in internal medicine at Johns Hopkins Medical Institution, and a fellowship in neuroendocrinology at the National Institutes of Health. Douglas taught clinical pharmacology at the Pritzker School of Medicine before becoming a professor of practice at MIT and establishing the Center for Biomedical Innovation. Prior to joining MIT, Douglas was EVP and Member of the Board of Management of Aventis AG. He was twice named Pharmaceutical R&D Director of the Year, received the Black History Maker Award in 2007, and in 2010 was named a GQ Magazine and Geoffrey Beane Foundation Rockstar of Science.
Douglas is currently president and CEO of THEVAX Genetics Vaccine USA and is president emeritus ofAusten BioInnovation Institue in Akron and senior partner emeritus of Puretech Ventures. He currently is a member of the Board of Directors of The Battellee Memorial Research Institute and previously was a member of the Board of Trustees at Lehigh University as well as the Board of Directors at the Kauffman Foundation, NitroMed, Gene Logic, and Altanos Pharmaceuticals Holding and was a member of the NCATS Scientific Advisory Board of the NIH.
Executive of the Year Award, Sales and Marketing Executive International, Akron Affiliate, 2013
Geoofrey Beene Foundation and GQ Magazine Rock Star of Science, 2010
Black History Makers Award, 2007
Medal of Honor, Johann Wolfgang von Goethe University of Frankfurt, 2004
Global Pharmaceutical Chief Scientific Officer of the Year Award, 2004
NOBCChe Lifetime Achievement Award, 2002
Global Pharmaceutical R&D Director of the Year Award, 2001
Louis B. Russell Memorial American Heart Association Award, 1986
Chicago Heart Association: Heart of the Year Award, 1985
- MIT Center for Biomedical Innovation biography
- Discrimination in academia – The Scientist article by Douglas